Dermatology
Scabies
0
Pipeline Programs↗
2
Active Trials↗
3
Companies Involved↗
Scabies is an early-stage landscape with 0 programs across 3 companies. The most active players are Saptalis Pharmaceuticals LLC, Mayne Pharma International Pty Ltd, Cipher Pharmaceuticals Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
9
clinical trials
Completed6 · 67%
Not yet recruiting1 · 11%
Unknown status1 · 11%
Recruiting1 · 11%
Clinical Trials
Trial Activity
9 trials
Sulfur vs. Different Regimes of Permethrin for Scabies
Completed·—·Phase 3·NCT06396507·250 enrolled
Better Disease Control by Multidrug Regimen in Scabies
Completed·—·N/A·NCT05198947·212 enrolled
Veron Scabies Education and Eradication Program
Completed·—·N/A·NCT00604084·1,057 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)